T L Schumacher1,2, T L Burrows1,2, M E Rollo1,2, L G Wood1,3, R Callister1,2, C E Collins1,2. 1. Faculty of Health and Medicine, University of Newcastle, Callaghan, New South Wales, Australia. 2. Priority Research Centre for Physical Activity and Nutrition, ATC Building, University of Newcastle and Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia. 3. Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Abstract
BACKGROUND/ OBJECTIVES: Limited dietary intake tools have been validated specifically for hyperlipidaemic adults. The Australian Eating Survey (AES) Food Frequency Questionnaire (FFQ) was adapted to include foods with cardio-protective properties (CVD-AES). The aims were to estimate dietary fatty acid (FA) intakes derived from the CVD-AES and AES and compare them with red blood cell (RBC) membrane FA content. SUBJECTS/ METHODS: Dietary intake was measured using the semi-quantitative 120-item AES and 177-item CVD-AES. Nutrient intakes were calculated using AUSNUT 2011-2013. Fasting RBC membrane FAs were assessed using gas chromatography. Extent of agreement between intakes estimated by AES or CVD-AES and RBC membrane composition (% of total FAs) for linoleic acid (LA), alpha-linolenic acid (ALA), eicosapentanoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) were assessed using Spearman's correlation coefficients, adjusted linear regressions and Kappa statistics. RESULTS: Data from 39 participants (72% female, 59.3±11.1 years) indicate stronger positive correlations between RBC membrane FAs and CVD-AES dietary estimates compared with the AES. Significant (P<0.05) moderate-strong correlations were found between CVD-AES FAs and FA proportions in RBC membranes for EPA (r=0.62), DHA (r=0.53) and DPA (r=0.42), with a moderate correlation for LA (r=0.39) and no correlation with ALA. Significant moderate correlations were found with the AES for DHA (r=0.39), but not for LA, ALA, EPA or DPA. CONCLUSIONS: The CVD-AES provides a more accurate estimate of long chain FA intakes in hyperlipidaemic adults, compared with AES estimates. This indicates that a CVD-specific FFQ should be used when evaluating FA intakes in this population.
BACKGROUND/ OBJECTIVES: Limited dietary intake tools have been validated specifically for hyperlipidaemic adults. The Australian Eating Survey (AES) Food Frequency Questionnaire (FFQ) was adapted to include foods with cardio-protective properties (CVD-AES). The aims were to estimate dietary fatty acid (FA) intakes derived from the CVD-AES and AES and compare them with red blood cell (RBC) membrane FA content. SUBJECTS/ METHODS: Dietary intake was measured using the semi-quantitative 120-item AES and 177-item CVD-AES. Nutrient intakes were calculated using AUSNUT 2011-2013. Fasting RBC membrane FAs were assessed using gas chromatography. Extent of agreement between intakes estimated by AES or CVD-AES and RBC membrane composition (% of total FAs) for linoleic acid (LA), alpha-linolenic acid (ALA), eicosapentanoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) were assessed using Spearman's correlation coefficients, adjusted linear regressions and Kappa statistics. RESULTS: Data from 39 participants (72% female, 59.3±11.1 years) indicate stronger positive correlations between RBC membrane FAs and CVD-AES dietary estimates compared with the AES. Significant (P<0.05) moderate-strong correlations were found between CVD-AESFAs and FA proportions in RBC membranes for EPA (r=0.62), DHA (r=0.53) and DPA (r=0.42), with a moderate correlation for LA (r=0.39) and no correlation with ALA. Significant moderate correlations were found with the AES for DHA (r=0.39), but not for LA, ALA, EPA or DPA. CONCLUSIONS: The CVD-AES provides a more accurate estimate of long chain FA intakes in hyperlipidaemic adults, compared with AES estimates. This indicates that a CVD-specific FFQ should be used when evaluating FA intakes in this population.
Authors: Barry A Franklin; J Larry Durstine; Christian K Roberts; R James Barnard Journal: Best Pract Res Clin Endocrinol Metab Date: 2014-01-22 Impact factor: 4.690
Authors: Sarah Lewington; Gary Whitlock; Robert Clarke; Paul Sherliker; Jonathan Emberson; Jim Halsey; Nawab Qizilbash; Richard Peto; Rory Collins Journal: Lancet Date: 2007-12-01 Impact factor: 79.321
Authors: Benjamin B Albert; José G B Derraik; David Cameron-Smith; Paul L Hofman; Sergey Tumanov; Silas G Villas-Boas; Manohar L Garg; Wayne S Cutfield Journal: Sci Rep Date: 2015-01-21 Impact factor: 4.379
Authors: Tracy L Burrows; Melinda J Hutchesson; Megan E Rollo; May M Boggess; Maya Guest; Clare E Collins Journal: Nutrients Date: 2015-05-06 Impact factor: 5.717
Authors: Lee M Ashton; Kristine B Pezdirc; Melinda J Hutchesson; Megan E Rollo; Clare E Collins Journal: Nutrients Date: 2017-12-23 Impact factor: 5.717
Authors: Francesco Landi; Anna Maria Martone; Sara Salini; Beatrice Zazzara; Riccardo Calvani; Emanuele Marzetti; Antonio Nesci; Angela Di Giorgio; Bianca Giupponi; Luca Santoro; Angelo Santoliquido Journal: Biomed Res Int Date: 2019-01-06 Impact factor: 3.411
Authors: Rachael Taylor; Vanessa A Shrewsbury; Lisa Vincze; Linda Campbell; Robin Callister; Felicity Park; Tracy Schumacher; Clare Collins; Melinda Hutchesson Journal: Front Cardiovasc Med Date: 2019-09-26
Authors: Ashleigh E Smith; Alexandra T Wade; Timothy Olds; Dorothea Dumuid; Michael J Breakspear; Kate Laver; Mitchell R Goldsworthy; Michael C Ridding; Monica Fabiani; Jillian Dorrian; Montana Hunter; Bryan Paton; Mahmoud Abdolhoseini; Fayeem Aziz; Maddison L Mellow; Clare Collins; Karen J Murphy; Gabriele Gratton; Hannah Keage; Ross T Smith; Frini Karayanidis Journal: BMJ Open Date: 2022-01-05 Impact factor: 2.692
Authors: Melinda J Hutchesson; Rachael Taylor; Vanessa A Shrewsbury; Lisa Vincze; Linda E Campbell; Robin Callister; Felicity Park; Tracy L Schumacher; Clare E Collins Journal: Int J Environ Res Public Health Date: 2020-08-10 Impact factor: 3.390